Molecular and functional studies of mechanisms that determine the efficacy of anti-hyperalgesic agents in persistent pain models.
Molecular and functional studies of mechanisms that determine the efficacy of anti-hyperalgesic agents in persistent pain models.
批准号:
BB/D018250/1
负责人:
Anthony Dickenson
金额:
$85.71万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pain is something we all experience in everyday life. It serves as a warning and survival message telling us of a threat to our body. Even the most primitive organisms such as slugs, snails and flies have mechanisms in their tiny nervous systems that allow them to escape damaging stimuli. Most of us have short-lasting pains but imagine that a headache, sprained ankle or period pain just went on and on and lasted for months and years on end. This is chronic pain. This chronic pain can arise from cancer, surgery, diseases such as rheumatism and arthritis and most people have a relation or know someone who has severe pain. This ongoing pain has a major impact on quality of life, disrupting social life, work, hobbies and furthermore, treatment can often be difficult. Nerves tell us what is happening in our bodies and in the outside world and by electrical and chemical events these messages are based on through our nervous system to the brain. If damage occurs to our visual system , our ability to see properly is lost and we may go blind. It is surprising how often our sensory nerves, nerves that signal pain and touch can be damaged. Examples could be an injury or even quite simple surgery. It is common that diseases such as diabetes, HIV and other viruses can lead to nerve damage. Most patients with damaged nerves have a loss of normal feeling and have numb areas. Remarkably, many patients also have severe and strange pains even though they have lost normal nerve function. One example would be phantom limbs where even through a part of the body has been removed by amputation, the person still 'feels' pain from the missing limb. Up to 25% of patients have severe and abnormal pains after nerve injury, leading to almost a million people in the UK. Pains from nerve injury include ongoing pain, allodynia, a very distressing state where mere touch or brushing is painful (patients often cannot bear the pressure of clothes or bedding, can't brush their hair) or hyperalgesia, (where a painful stimulus is many times worse than normal). These suggest the nervous system has been changed by the nerve injury. We want to find out what has happened in the nerves, spinal cord and brain to produce these abnormal pains. Patients with these pains not unexpectedly, often are depressed, anxious and can't sleep well. We have shown that the parts of the brain that deal with these emotions also change pain signals. How do these nervous pathways talk to each other and why do they change when nerves are damaged. A drug, gabapentin, (GBP) is the main treatment for nerve injury pain but it only works well in 1 in 3 patients and has no effect on ordinary pains. We want to find out why this is the case and understand how it only changes abnormal activity such as that caused by nerve injury. A chemical messenger in the brain called 5HT, important in mood and sleep, may be a key to the injury-linked pain reducing actions of gabapentin. Therefore this application will bring together 3 applicants using a wide range of modern techniques to understand how our nervous system is changed by external events such as pain and how and why drugs work. Knowledge of what determines this should allow greater numbers of patients to gain relief from this distressing pain state. It should enable us to understand how our nerves, spinal cord and brain have the ability to change the way they respond and interact in response to external stimuli, internal thoughts and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
-
批准号:82371873
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:乔洁
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
-
批准号:82372160
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈峰
-
依托单位:
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
-
批准号:82371997
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张春富
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
LTB4/BLT1轴调控NLRP3炎症小体对糖尿病认知功能障碍的作用研究
-
批准号:82371213
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:王修哲
-
依托单位:
Identification and quantification of primary phytoplankton functional types in the global oceans from hyperspectral ocean color remote sensing
-
批准号:--
-
项目类别:--
-
资助金额:160万元
-
批准年份:2022
-
负责人:李忠平
-
依托单位:
浸润特性调制的统计热力学研究
-
批准号:21173271
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:周世琦
-
依托单位: